DOUG HASTINGS is a nationally recognized health care transaction lawyer and advisor on health system change. For more than 30 years, Mr. Hastings and his colleagues at Epstein Becker Green have designed, implemented, and successfully closed scores of complex health care transactions on behalf of hospitals, health systems, academic medical centers, post-acute providers, large medical groups, and health plans. Described in Chambers USA as a "transactional genius," he advises clients on the strategic considerations, corporate architecture, and regulatory compliance components of proposed transactions, including the payment and delivery reform, governance, antitrust, exempt tax, and fraud and abuse implications.
Since 2001, he has been closely involved at the national level with efforts to improve the quality and cost efficiency of the U.S. health care system, and is known for his role in the launch of accountable care organizations in both the public and private sectors.
Mr. Hastings served on the Board on Health Care Services of the Institute of Medicine (IOM) from 2003 to 2011 and on the IOM's Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care from 2010 to 2013. He is a Past President and Fellow of the American Health Lawyers Association. Named in 2006 as the first Chair of the Board of Directors of Epstein Becker Green, Mr. Hastings served in that role until January 1, 2014.
Currently, Mr. Hastings serves as a member of the Board of Directors of Guthrie Health and the Quality and Community Benefit Committee of Riverside Health System. In addition, he serves on the advisory boards of Accountable Care News and BNA's Health Law Reporter. In 2013, he was elected to membership in the Healthcare Executives Study Society, a group primarily comprised of large health system CEOs that seeks to advance the state and art of executive leadership and influence the development of health care public policy.
Mr. Hastings is listed in Chambers USA, in Band 1, for health care transactions nationally. In 2013, Chambers noted that he is "'nationally known for his healthcare and legal expertise ... a visionary, extremely informed as to future implications of the health reform.'" Mr. Hastings was elected to the 2013 BTI Client Service All-Star Team for his "extraordinary client service" and "willingness to go above and beyond expectations." In 2011, Mr. Hastings was named to The National Law Journal's list of "Most Influential Lawyers." In 2010, he was presented with the David J. Greenburg Service Award from the American Health Lawyers Association; he received the BNA Insights Award for his article "The Timeline for Accountable Care"; and he was named by Nightingale's Healthcare News as one of the 10 significant health care industry decision-makers. Mr. Hastings has been selected by his peers for inclusion in The Best Lawyers in America© (2007 to 2015) in the field of Health Care Law and recommended by The Legal 500 United States (2011 to 2014). He has also been named to the Washington DC Super Lawyers list (2007 to 2014) in the area of Health Care.
Mr. Hastings speaks and publishes regularly on topics related to accountable care and clinical integration, corporate governance, collaborative health care ventures, legal issues related to health care transactions and quality improvement, and the legal trends influencing the U.S. health care system.
He is a graduate of Duke University and the University of Virginia Law School.
- University of Virginia (J.D.)
- Order of the Coif
- Duke University (B.A.)
- Phi Beta Kappa
- District of Columbia
- New York
- American Bar Association, Health Law Section
- American Health Lawyers Association, President (2001 - 2002), Fellow (2005 - present)
- Health Executives Study Society
- Health Insights Foundation
- Institute of Medicine, Board on Health Care Services (2003 - 2011)
- National Quality Forum